Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
Clinical trial NCT00510068 · COMPLETED
Trial details
- NCT number
- NCT00510068
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2010-02-01
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.